PROS1 and Alzheimer disease: Furthermore, we conducted correlation analyses between serum PROS1 levels and two AD neuroimaging biomarkers: global amyloid retention according to [11C] Pittsburgh compound B (PiB)-positron emission tomography (PET) and the adjusted hippocampal volume (HVa) according to magnetic resonance imaging.